Loading...
The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia
Accumulating evidence suggests that a dysregulation of the glutamatergic system exists in the brains of schizophrenia patients. The metabotropic glutamate (mGlu) receptors are being investigated as novel drug targets for this disease, and have shown promise in both preclinical and clinical studies....
Na minha lista:
| Udgivet i: | Curr Opin Pharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5949078/ https://ncbi.nlm.nih.gov/pubmed/29486374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2018.02.003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|